Companies researching Opdivo (nivolumab)
Opdivo, known generically as nivolumab, is an immunotherapy medication employed to treat multiple forms of cancer.
13
companies
List of companies that research Opdivo (nivolumab)
This is sourced from job postings — companies only hire for what they actively use or plan to adopt · how we source this →
| Company | Country | Industry | Employees | Revenue | Technologies |
|---|---|---|---|---|---|
United States | Pharmaceutical Manufacturing | 39k | $46B | Opdivo (nivolumab) | |
United States | Hospitals and Health Care | 1.5k | Opdivo (nivolumab) | ||
United States | Pharmaceutical Manufacturing | 3.4k | $15M | Opdivo (nivolumab) | |
United States | Business Consulting and Services | 1.2k | Opdivo (nivolumab) | ||
United States | Business Consulting and Services | 97 | $18M | Opdivo (nivolumab) | |
United States | Hospitals and Health Care | 21k | $5.5B | Opdivo (nivolumab) | |
France | Hospitals and Health Care | 3k | Opdivo (nivolumab) | ||
United States | Non-profit Organizations | 96 | Opdivo (nivolumab) | ||
United States | Medical Practices | 201 | $36M | Opdivo (nivolumab) | |
Netherlands | Research Services | 620 | Opdivo (nivolumab) |
Showing top companies out of 13 that research Opdivo (nivolumab). Get the full list on TheirStack.
Frequently asked questions






